Cargando…
The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis
OBJECTIVE: The soluble urokinase plasminogen activator receptor (suPAR) is associated with kidney diseases and is used as a prognostic factor of renal function progression. The aim of this study was to explore whether circulating suPAR was associated with antineutrophil cytoplasmic autoantibody- (AN...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166284/ https://www.ncbi.nlm.nih.gov/pubmed/32322165 http://dx.doi.org/10.1155/2020/7850179 |
_version_ | 1783523528361902080 |
---|---|
author | Huang, Fei Li, Yueqiang Xu, Ranran Cheng, Anying Lv, Yongman Liu, Qingquan |
author_facet | Huang, Fei Li, Yueqiang Xu, Ranran Cheng, Anying Lv, Yongman Liu, Qingquan |
author_sort | Huang, Fei |
collection | PubMed |
description | OBJECTIVE: The soluble urokinase plasminogen activator receptor (suPAR) is associated with kidney diseases and is used as a prognostic factor of renal function progression. The aim of this study was to explore whether circulating suPAR was associated with antineutrophil cytoplasmic autoantibody- (ANCA-) associated vasculitis (AAV) disease activity. METHODS: We evaluated 90 AAV patients with follow-up data and 35 normal controls; their plasma suPAR and C-reactive protein (CRP) levels were measured by ELISA. Associations between these levels, clinical parameters, and prognosis were analyzed. RESULTS: Plasma suPAR levels in AAV patients were significantly higher than in healthy controls (5,920.08 ± 3,447.17 vs. 1,441.97 ± 835.04 pg/mL, P < 0.001). Furthermore, suPAR was significantly elevated in AAV patients in active stage compared to those in partial remissions (6,492.19 ± 3,689.48 vs. 5,031.86 ± 2,489.01 pg/mL, P = 0.039). Correlation analyses demonstrated that suPAR levels positively correlated with initial serum creatinine, BVAS, CRP, and procalcitonin concentration, and negatively correlated with eGFR and C3 circulating levels. In a Kaplan-Meier survival analysis, patients with plasma suPAR levels >5683.3 pg/mL showed poorer survival than patients with lower levels (log-rank, P = 0.001). Besides, multivariate analyses confirmed that plasma suPAR levels were an independent adverse prognostic factor for a composite outcome of end-stage renal disease (ESRD) or death, after adjusting for age and gender (HR 1.05, 95% CI = 1.01 − 1.11, P = 0.043). Receiver operating characteristic curves showed a suPAR cutoff value >6662.2 pg/mL for composite outcome with 68% sensitivity and 88% specificity, with an AUC = 0.82, (95% CI = 0.68 − 0.96, P < 0.001). CONCLUSION: Circulating suPAR levels might be a marker of activity correlated with disease activity in AAV patients, and, to some extent, could be a factor of poor prognosis. |
format | Online Article Text |
id | pubmed-7166284 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-71662842020-04-22 The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis Huang, Fei Li, Yueqiang Xu, Ranran Cheng, Anying Lv, Yongman Liu, Qingquan Mediators Inflamm Research Article OBJECTIVE: The soluble urokinase plasminogen activator receptor (suPAR) is associated with kidney diseases and is used as a prognostic factor of renal function progression. The aim of this study was to explore whether circulating suPAR was associated with antineutrophil cytoplasmic autoantibody- (ANCA-) associated vasculitis (AAV) disease activity. METHODS: We evaluated 90 AAV patients with follow-up data and 35 normal controls; their plasma suPAR and C-reactive protein (CRP) levels were measured by ELISA. Associations between these levels, clinical parameters, and prognosis were analyzed. RESULTS: Plasma suPAR levels in AAV patients were significantly higher than in healthy controls (5,920.08 ± 3,447.17 vs. 1,441.97 ± 835.04 pg/mL, P < 0.001). Furthermore, suPAR was significantly elevated in AAV patients in active stage compared to those in partial remissions (6,492.19 ± 3,689.48 vs. 5,031.86 ± 2,489.01 pg/mL, P = 0.039). Correlation analyses demonstrated that suPAR levels positively correlated with initial serum creatinine, BVAS, CRP, and procalcitonin concentration, and negatively correlated with eGFR and C3 circulating levels. In a Kaplan-Meier survival analysis, patients with plasma suPAR levels >5683.3 pg/mL showed poorer survival than patients with lower levels (log-rank, P = 0.001). Besides, multivariate analyses confirmed that plasma suPAR levels were an independent adverse prognostic factor for a composite outcome of end-stage renal disease (ESRD) or death, after adjusting for age and gender (HR 1.05, 95% CI = 1.01 − 1.11, P = 0.043). Receiver operating characteristic curves showed a suPAR cutoff value >6662.2 pg/mL for composite outcome with 68% sensitivity and 88% specificity, with an AUC = 0.82, (95% CI = 0.68 − 0.96, P < 0.001). CONCLUSION: Circulating suPAR levels might be a marker of activity correlated with disease activity in AAV patients, and, to some extent, could be a factor of poor prognosis. Hindawi 2020-04-07 /pmc/articles/PMC7166284/ /pubmed/32322165 http://dx.doi.org/10.1155/2020/7850179 Text en Copyright © 2020 Fei Huang et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Huang, Fei Li, Yueqiang Xu, Ranran Cheng, Anying Lv, Yongman Liu, Qingquan The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis |
title | The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis |
title_full | The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis |
title_fullStr | The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis |
title_full_unstemmed | The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis |
title_short | The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis |
title_sort | plasma soluble urokinase plasminogen activator receptor is related to disease activity of patients with anca-associated vasculitis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166284/ https://www.ncbi.nlm.nih.gov/pubmed/32322165 http://dx.doi.org/10.1155/2020/7850179 |
work_keys_str_mv | AT huangfei theplasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis AT liyueqiang theplasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis AT xuranran theplasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis AT chenganying theplasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis AT lvyongman theplasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis AT liuqingquan theplasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis AT huangfei plasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis AT liyueqiang plasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis AT xuranran plasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis AT chenganying plasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis AT lvyongman plasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis AT liuqingquan plasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis |